Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.
Right arrow Articles by Zhou, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.
Right arrow Articles by Zhou, D.
[Cancer Research 64, 6240-6246, September 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

Activation of Nuclear Factor {kappa}B In vivo Selectively Protects the Murine Small Intestine against Ionizing Radiation-Induced Damage

Yong Wang1, Aimin Meng1, Hainan Lang2, Stephen A. Brown4,5, Jennifer L. Konopa4, Mark S. Kindy3, Richard A. Schmiedt2, John S. Thompson4,5 and Daohong Zhou1

Departments of 1 Pathology and Laboratory Medicine, 2 Otolaryngology-Head and Neck Surgery, and 3 Physiology and Neuroscience, Medical University of South Carolina, Charleston, South Carolina; 4 Department of Medicine, University of Kentucky, Lexington, Kentucky; and 5 Veterans Administration Medical Center, Lexington, Kentucky

Exposure of mice to total body irradiation induces nuclear factor {kappa}B (NF{kappa}B) activation in a tissue-specific manner. In addition to the spleen, lymph nodes, and bone marrow, the tissues that exhibit NF{kappa}B activation now include the newly identified site of the intestinal epithelial cells. NF{kappa}B activated by total body irradiation mainly consists of NF{kappa}B p50/RelA heterodimers, and genetically targeted disruption of the NF{kappa}B p50 gene in mice significantly decreased the activation. By comparing tissue damage and lethality in wild-type and NF{kappa}B p50 knockout (p50–/–) mice after they were exposed to increasing doses of total body irradiation, we additionally examined the role of NF{kappa}B activation in total body irradiation-induced tissue damage. The results show that p50–/– mice are more sensitive to total body irradiation-induced lethality than wild-type mice (LD50/Day 7: wild-type = 13.12 Gy versus p50–/– = 7.75 Gy and LD50/Day 30: wild-type = 9.31 Gy versus p50–/– = 7.81 Gy). The increased radiosensitivity of p50–/– mice was associated with an elevated level of apoptosis in intestinal epithelial cells and decreased survival of the small intestinal crypts compared with wild-type mice (P < 0.01). In addition, RelA/TNFR1-deficient (RelA/TNFR1–/–) mice also exhibited a significant increase in intestinal epithelial cell apoptosis after they were exposed to total body irradiation as compared with TNFR1-deficient (TNFR1–/–) mice (P < 0.01). In contrast, no significant increase in total body irradiation-induced apoptosis or tissue injury was observed in bone marrow cells, spleen lymphocytes, and the liver, heart, lung, and kidney of p50–/– mice in comparison with wild-type mice. These findings indicate that activation of NF{kappa}B selectively protects the small intestine against ionizing radiation-induced damage.




This article has been cited by other articles:


Home page
ScienceHome page
L. G. Burdelya, V. I. Krivokrysenko, T. C. Tallant, E. Strom, A. S. Gleiberman, D. Gupta, O. V. Kurnasov, F. L. Fort, A. L. Osterman, J. A. DiDonato, et al.
An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
Science, April 11, 2008; 320(5873): 226 - 230.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Vodanovic-Jankovic, P. Hari, P. Jacobs, R. Komorowski, and W. R. Drobyski
NF-{kappa}B as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145
Blood, January 15, 2006; 107(2): 827 - 834.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.